PRAH Insider Trading Activity and SEC Form 4 Filings
PRAH insider trading summary
No open-market insider purchases or sales of PRA Health Sciences, Inc. (PRAH) have been reported on SEC Form 4 in the past 12 months.
Latest PRAH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 17, 2021 | Michael J. Bonello | EVP & CFO | Sell | $33K (200 @ $166.70) |
| Jun 17, 2021 | Christopher L Gaenzle | EVP, CAO & General Counsel | Sell | $117K (692 @ $169.75) |
| Jun 17, 2021 | Christopher L Gaenzle | EVP, CAO & General Counsel | Sell | $2.3M (13,391 @ $168.06) |
| Jun 17, 2021 | Colin Shannon | President & CEO | Sell | $27.1M (161,352 @ $168.13) |
| Jun 17, 2021 | Michael J. Bonello | EVP & CFO | Sell | $3.8M (22,587 @ $169.05) |
| Jun 17, 2021 | Michael J. Bonello | EVP & CFO | Sell | $4.1M (24,389 @ $168.17) |
| Jun 17, 2021 | Colin Shannon | President & CEO | Sell | $37.2M (220,195 @ $169.00) |
| Jun 17, 2021 | Colin Shannon | President & CEO | Sell | $10.1M (59,774 @ $169.63) |
| Jun 17, 2021 | Colin Shannon | President & CEO | Sell | $154K (920 @ $166.89) |
| Jun 17, 2021 | Michael J. Bonello | EVP & CFO | Sell | $912K (5,375 @ $169.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.